Mortality predictors in critically ill patients with acute kidney injury requiring continuous renal replacement therapy
- Author:
Kristianne Rachel P. MEDINA-LIABRES
1
;
Jong Cheol JEONG
;
Hyung Jung OH
;
Jung Nam AN
;
Jung Pyo LEE
;
Dong Ki KIM
;
Dong-Ryeol RYU
;
Sejoong KIM
Author Information
- Publication Type:Original Article
- From:Kidney Research and Clinical Practice 2021;40(3):401-410
- CountryRepublic of Korea
- Language:English
-
Abstract:
Background:Because of high cost of continuous renal replacement therapy (CRRT) and the high mortality rate among severe acute kidney injury patients, careful identification of patients who will benefit from CRRT is warranted. This study determined factors associated with mortality among critically ill patients requiring CRRT.
Methods:This was a retrospective observational study of 414 patients admitted to the intensive care unit of four hospitals in South Korea who received CRRT from June 2017 to September 2018. Patients were divided according to degree of fluid overload (FO) and disease severity. The Cox proportional hazards model was used to explore the effect of relevant variables on mortality.
Results:In-hospital mortality rate was 57.2%. Ninety-day mortality rate was 58.5%. Lower creatinine and blood pH were significant predictors of mortality. A one-unit increase in the Sequential Organ Failure Assessment (SOFA) score was associated with increased risk of and 90-day mortality (hazard ratio [HR], 1.07; p < 0.001). The risk of 90-day mortality in FO patients was 57.2% (p < 0.001) higher than in those without FO. High SOFA score was associated with increased risk for 90-day mortality (HR, 1.79; p = 0.03 and HR, 3.05; p = 0.001) in patients without FO and with FO ≤ 10%, respectively. The highest mortality rates were in patients with FO > 10%, independent of disease severity.
Conclusion:FO increases the risk of mortality independent of other factors, including severity of acute illness. Prevention of FO should be a priority, especially when managing the critically ill.
